[{"address1": "Clarence Thomas Building", "address2": "P.O. Box 4649 Road Town", "city": "Tortola", "zip": "VG1110", "country": "British Virgin Islands", "phone": "302 219 5556", "website": "https://www.portagebiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline comprises PORT-3, a polylactide-co-glycolide, which is in phase 1 to treat NY-ESO-1 positive tumors; PORT-6, a highly selective A2A receptor antagonist, which is in phase 1a for the treatment of solid tumors; PORT-8, a dual inhibitor of adenosine receptors 2A and 2B, which is in preclinical trial to treat solid tumors; PORT-9, an A2B antagonist, which is in pre-clinical stage program to treat colorectal and gastrointestinal cancers; PORT-4, a nanolipogel co-formulations to treat of solid tumors that is in preclinical trials; PORT-5, a VLP-STING to treat of solid tumors and is in preclinical trials; and PORT-7, a potent and selective antagonist of the adenosine A2B receptor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Mr. Alexander  Pickett", "age": 36, "title": "CEO & Director", "yearBorn": 1988, "fiscalYear": 2025, "totalPay": 102870, "exercisedValue": 0, "unexercisedValue": 43200}, {"maxAge": 1, "name": "Dr. Robert A. Kramer Ph.D.", "age": 72, "title": "Chief Scientific Officer", "yearBorn": 1952, "fiscalYear": 2025, "totalPay": 119250, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Adam  Melero", "title": "Controller", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Molloy", "title": "Chief Executive Officer of Cyncado Therapeutics Inc.", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.84, "open": 10.06, "dayLow": 8.0801, "dayHigh": 10.06, "regularMarketPreviousClose": 9.84, "regularMarketOpen": 10.06, "regularMarketDayLow": 8.0801, "regularMarketDayHigh": 10.06, "payoutRatio": 0.0, "beta": 0.599, "forwardPE": -17.884617, "volume": 121341, "regularMarketVolume": 121341, "averageVolume": 99349, "averageVolume10days": 58910, "averageDailyVolume10Day": 58910, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 21191166, "fiftyTwoWeekLow": 2.1, "fiftyTwoWeekHigh": 23.01, "fiftyDayAverage": 6.46758, "twoHundredDayAverage": 5.854465, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 18817184, "profitMargins": 0.0, "floatShares": 1454855, "sharesOutstanding": 2278620, "sharesShort": 51030, "sharesShortPriorMonth": 8761, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0224, "heldPercentInsiders": 0.37101, "heldPercentInstitutions": 0.04626, "shortRatio": 0.22, "shortPercentOfFloat": 0.026400002, "impliedSharesOutstanding": 2278620, "bookValue": -0.074, "lastFiscalYearEnd": 1743379200, "nextFiscalYearEnd": 1774915200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -6767000, "trailingEps": -5.72, "forwardEps": -0.52, "lastSplitFactor": "1:20", "lastSplitDate": 1723680000, "enterpriseToEbitda": -2.549, "52WeekChange": 2.3233333, "SandP52WeekChange": 0.19554341, "quoteType": "EQUITY", "currentPrice": 9.3, "recommendationKey": "none", "totalCash": 1670000, "totalCashPerShare": 0.733, "ebitda": -7383000, "totalDebt": 0, "quickRatio": 1.529, "currentRatio": 2.023, "returnOnAssets": -0.92688006, "returnOnEquity": -5.41807, "freeCashflow": -3330125, "operatingCashflow": -5462000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PRTG", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1754685052, "regularMarketTime": 1754683200, "exchange": "NCM", "messageBoardId": "finmb_233586353", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "cryptoTradeable": false, "marketState": "CLOSED", "regularMarketChangePercent": -5.4878, "regularMarketPrice": 9.3, "shortName": "Portage Biotech Inc.", "longName": "Portage Biotech Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1009981800000, "postMarketChangePercent": -3.65592, "postMarketPrice": 8.96, "postMarketChange": -0.34, "regularMarketChange": -0.54, "regularMarketDayRange": "8.0801 - 10.06", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 99349, "fiftyTwoWeekLowChange": 7.2000003, "fiftyTwoWeekLowChangePercent": 3.4285717, "fiftyTwoWeekRange": "2.1 - 23.01", "fiftyTwoWeekHighChange": -13.71, "fiftyTwoWeekHighChangePercent": -0.5958279, "fiftyTwoWeekChangePercent": 232.33333, "dividendDate": 1591228800, "earningsTimestampStart": 1756324800, "earningsTimestampEnd": 1756324800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -5.72, "epsForward": -0.52, "fiftyDayAverageChange": 2.8324203, "fiftyDayAverageChangePercent": 0.4379413, "twoHundredDayAverageChange": 3.4455352, "twoHundredDayAverageChangePercent": 0.5885312, "priceToBook": -125.675674, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-25", "displayName": "Portage Biotech", "trailingPegRatio": null, "__fetch_time": "2025-08-09"}]